Psychiatry Investig Search


Psychiatry Investig > Volume 20(5); 2023 > Article
Kim, Jang, Rim, Kim, Chang, and Woo: Attachment Insecurity and Stigma as Predictors of Depression and Anxiety in People Living With HIV



The purpose of this study was to examine whether attachment insecurity, stigma, and certain demographic and medical factors predict depression and anxiety in people living with HIV (PLWH).


Participants were 147 PLWH who visited the outpatient infection clinic in Kyungpook National University Hospital (KNUH; Daegu, South Korea) between June 2020 and January 2021. We measured HIV-related stigma, attachment anxiety and avoidance, depressive symptoms, and anxiety symptoms.


Logistic regression analysis showed that unemployment, longer time receiving antiretroviral therapy, higher attachment avoidance, and higher attachment anxiety were significant predictors of depression. Results also showed that longer time receiving antiretroviral therapy, higher attachment anxiety, and concern with public attitudes were significant predictors of anxiety.


In addition to education to reduce public stigma, interventions to reduce PLWH’s self-stigma should continue. We suggest attachment-based psychotherapy as an effective intervention to improve PLWH’s mental health.


The introduction of combination antiretroviral therapy (ART) has changed the concept of HIV infection from a life-threatening terminal disease to a controllable chronic disease [1]. There has been a considerable amount of research estimating the life expectancy of people living with HIV (PLWH) is approaching that of the general population [2-4]. With prolonged life expectancies, many recent studies have focused on the various mental health aspects of PLWH.
The projections of mortality and burden of disease to 2030 were initiated by the World Health Organization and it is estimated that along with AIDS and ischemic heart disease, unipolar depression will be one of the three diseases of most significant burden worldwide [5]. Depression is the most common neuropsychiatric complication among PLWH and have reported a two to four times higher prevalence than in general population [6]. Anxiety disorders are also prevalent among PLWH. Depression and anxiety are associated with sexual risk behaviors, nonadherence to HIV medications, progression to AIDS, higher mortality rates and low quality of life (QOL) [7-9]. These psychiatric disorders can subsequently lead to a more complicated clinical course in adapting to HIV care.
Several demographic and clinical factors are known as risk factors for depression and anxiety in people with HIV infection. A review paper that studied depression in PLWH stated that the depression prevalence was high when the infected person is female, in their 50s or older, when there is no residence, unemployment, and lower income. Increased level of HIV-RNA is also known as risk factor for depression [6]. Another study identified that sexual orientation and emergency of HIV-related symptoms as predictors of depression and anxiety in PLWH [10].
Many studies have noted that the stigma related to HIV could be a considerable barrier to HIV prevention and treatment. Some recent studies have attempted to examine the mechanisms of HIV-related stigma at an individual level. Earnshaw and colleagues [11,12] suggested the HIV Stigma Framework (HSF) for PLWH, to explore how the stigma of HIV elicits a series of stigma mechanisms and leads to deleterious outcomes including affective, behavioral, and physical health and well-being. Studies have been conducted around African, Western, and some Asian countries to reduce HIV-related stigma and have been shown to be effective in reducing stigma at an individual or social levels [13]. However, HIV-related stigma is still prevalent around the world, affecting patients’ emotional and physical well-being.
Being able to connect and rely emotionally on others helps prevent and reduce mental and medical problems in many diseases. In this context, attachment security is becoming more important in medical settings. Several studies have shown that attachment security in patients with chronic diseases such as diabetes, systemic lupus erythematosus, and cancer affects patients’ QOL, disease management, and disease adaptation [14-16].
According to attachment theory, based on previous support experiences with other people affected the development of internal working models of close relationships. These models can affect an individual’s perceptions of others’ availability in a stressful situation and how to handle stressors [17,18]. Although early life relationship models have an impact on life as a whole, they are likely to evolve as individuals develop new relationships or experiences [19]. Close relationships can increase emotional control, which can also reduce attachment insecurity, such as attachment anxiety, by reducing negative emotions [20]. It can also be assumed that negative relationships or experiences are likely to increase attachment insecurity. A review of post-traumatic stress disorder found that patients treated after HIV diagnosis had more prevalent trauma symptoms than other chronic diseases, similar to those treated in intensive care units [21]. Previous studies have shown that the degree of trauma symptoms is closely related to attachment security [22]. The frequency of trauma symptoms in PLWH may be attributed to frequent exposure to traumatic life events before they were diagnosed with HIV, or to experiences resulting from the HIV diagnosis itself. In any case, a series of traumatic experiences or relationships may have affected the attachment security of individuals who were diagnosed with HIV and may have affected changes in the attachment system. Therefore, it can be assumed that PLWH have differences in attachment security compared to the general population or other chronic diseases [23].
Few studies have focused on the link between attachment security and emotional or psychical well-being among PLWH. In previous studies, researchers have shown that individuals coping with HIV were significantly associated with less secure and more anxious attachment styles. A study with the degree of adjustment of PLWH also suggested that secure attachment is highly related to experiencing positive disease adaptation [24,25]. There was another suggestion that attachment insecurity, especially attachment anxiety can act as a buffer between perceived and internalized stigma and can indirectly change mental health and behavior of PLWH [26]. Through these studies, it can be assumed that not only stigma but also patients’ attachment security would be a factor affecting PLWH’s physical and mental health.
Although some of the studies have noted the correlation of attachment security and HIV-related stigma that affects the mental health of PLWH, there is still a lack of research in this area. For this reason, our study has focused on HIV-related stigma and attachment insecurity as psychosocial factors that can affect depression and anxiety in PLWH. This study was conducted to determine whether HIV-related stigma, attachment insecurity, and other demographic and clinical factors of PLWH serve as factors for predicting depression and anxiety.



Participants were 147 PLWH who visited the outpatient infection clinic in Kyungpook National University Hospital (KNUH; Daegu, South Korea) between June 2020 and January 2021. Patients were eligible to participate if they met the following criteria: 1) had been diagnosed with HIV infection, 2) were currently on an ART regimen, 3) were age 20 years or older, 4) were able to give written informed consent, and 5) were able to read and write in Korean. All participants provided written informed consent (in Korean) after we had explained the study. This study was approved by the Institutional Review Board of Kyungpook National University Hospital (KNUH IRB file no. 2020-03-034).

Sociodemographic and clinical data

Participants reported their demographic information, HIV transmission route, experience with AIDS-related diseases, ART start date, and ART adherence. To measure ART adherence, participants answered the question “How often have you missed your medication in the last four weeks?” We dichotomized responses as “very good” if the answer was “not more than once” and “not very good” if the answer was “more than once.” We extracted clinical data from the patients’ medical records, including total CD4 T-cell counts (cell/μL) and HIV quantitative real time polymerase chain reaction (RT PCR) (copies/mL).


HIV-related stigma

We used the revised HIV Stigma Scale (HSS-R) [27,28] in this study to measure HIV-related stigma. The HSS-R is an abbreviated version (32 items) of the original 40-item scale and contains four subscales. Enacted stigma is related to the personal experience of rejection. Disclosure concerns are HIV-positive individuals’ need to keep their HIV diagnosis concealed. Negative self-image provides information about PLWH’s feelings of inferiority and shame. Concern with public attitudes addresses what PLWH believe that other individuals might think about them. Participants rated items for each subscale using a 4-point Likert scale ranging from 1 (“strongly agree”) to 4 (“strongly disagree”). The Cronbach’s alpha for the 32-item Korean version of the HSS-R were measured based on the data collected under the present study, and it was 0.897 for the total scale, indicating good internal consistency. All subscales demonstrated similarly strong internal consistency (enacted stigma: 0.933; disclosure concerns: 0.785; negative self-image: 0.822; concerns with public attitudes: 0.834). However, as 57 of the 147 participants (38.8%) in our study had no experience informing other individuals about their HIV/AIDS status, enacted stigma was difficult to measure.

Attachment insecurity

We used the Modified Experiences in Close Relationships Scale (ECR-M16) to measure participants’ experiences in close romantic and nonromantic relationships across two domains: attachment anxiety and attachment avoidance [29,30]. This is a shortened version of the ECR-M36, and existing research has found the ECR-M36 to be a useful tool for understanding attachments to close family, friends, and medical staff during the course of serious illness [31,32]. The ECR-M16 contains 16 items scored on a 7-point Likert scale ranging from 1 (“disagree”) to 7 (“agree”), with total scores ranging from 8 to 56 on each subscale. High scores on each subscale indicate high attachment insecurity. The full scale’s Cronbach’s alpha of 0.816 demonstrated the Korean version of the ECR-M16’s good internal consistency based on the data collected in this study. The eight-item attachment anxiety subscale also demonstrated good internal consistency (Cronbach’s alpha=0.880), and the eight-item attachment avoidance subscale’s internal consistency was acceptable (Cronbach’s alpha=0.649).


We measured depressive symptoms using the Korean version of the Patient Health Questionnaire-9 (PHQ-9) [33]. The PHQ-9 assesses nine criteria on which the DSM-IV diagnosis of major depressive disorder is based. The nine items utilize a 4-point Likert scale from 0 (“not at all”) to 3 (“nearly every day”). Total scores range from 0 to 27. Currently, the recommended single screening cutoff score for major depressive disorder diagnosis is 10 or greater [34,35], which we also used in our study.


We measured anxiety symptoms using the Korean version of the Generalized Anxiety Disorder-7 (GAD-7) [36,37]. On a 4-point Likert scale ranging from 0 (“not at all”) to 3 (“nearly every day”), participants rated how often they have experienced feelings of nervousness, worry, or restlessness in the past two weeks. Total scores range from 0 to 21. In the Korean version, a score of 8 or greater represents an optimal cutoff value for identifying cases of generalized anxiety disorder, which we applied in our study to indicate the presence or absence of anxiety.

Statistical analysis

First, preliminary analyses were performed to identify significant group differences within the sample. Chi-square tests were conducted using categorical variables: gender, marriage, employment, education, monthly income, religion, HIV transmission route, experience with AIDS-related diseases, and ART adherence. Fisher’s exact test was applied when more than 20% of cells had expected frequencies lower than 5. Cutoff levels for PHQ-9 were 10 points or more, GAD-7 were 8 points or more. Also, Pearson correlation analyses were conducted for continuous variables: ART period from start, total CD4 T-cell count, HIV quantitative RT PCR, attachment anxiety, attachment avoidance, disclosure concerns, negative self-image, concern with public attitudes, PHQ-9, and GAD-7.
Second, the backward stepwise binary logistic regression analysis using log-likelihood ratio statistic was performed to determine the predictors for depression and anxiety. All the sociodemographic, medical, and psychological variables investigated in this study were included in the analysis to determine potential explanatory variables. We used SPSS version 21 for Windows (IBM Corp., Armonk, NY, USA) for all analyses.


Participants’ sociodemographic, clinical, and psychiatric characteristics

The mean age of participants was 42.7 (standard deviation [SD]=12.5) years, and the majority were male (n=142, 96.6%). Most participants were single (68.0%), employed (65.3%), had a monthly income of 3 million KRW or less (66.7%), had no religion (65.3%), had not experienced AIDS-related diseases (68.7%), and had very good ART adherence (89.8%). The proportion of groups that continued their education after high school and those who did not were similar. Almost half the participants reported their HIV transmission route via homosexual or bisexual behavior (45.6%). The mean ART period was 71.3 (SD=58.6) months, the mean CD4 T-cell count (cells/μL) was 610.3 (SD=428.7), and the mean HIV quantity based on RT PCR analysis (copies/mL) was 8,544.9 (SD=87,642.9) (Table 1). After the survey for demographics, researchers tried to minimize missing data thorough question and answer with the participants, but if the participant did not wish to answer the question, it was processed as missing data, some data showed that the total number did not satisfy 147.
The mean score on the PHQ-9 was 5.9 (SD=6.3) and on the GAD-7 was 4.4 (SD=4.8). Participants with depression (PHQ-9 score ≥10) comprised 21.8% (n=32) of the sample, and those with anxiety (GAD-7 score ≥8) accounted for 23.1% (n=34). The mean score on the ECR-M16 attachment anxiety subscale was 24.7 (SD=10.8) and on the attachment avoidance subscale was 30.3 (SD=8.2). As for the HSS-R, the mean score on the disclosure concerns subscale was 25.2 (SD=5.1). The mean negative self-image score was 17.8 (SD=4.9), and that for the concern with public attitudes subscale was 19.0 (SD=4.2) (Table 2).

Comparing groups with or without depression or anxiety

The results of the chi-square test showed that the proportion of depressed participants was significantly higher in the unemployed group than in the employed group (p=0.009). The mean values for the ART period (p=0.018), GAD-7 (p<0.001), attachment anxiety (p<0.001), attachment avoidance (p<0.001), negative self-image (p=0.012), and concerns with public attitudes (p<0.001) were statistically significantly higher for depressed participants than for those without depression (Table 3).
Like depression, anxiety was significantly more frequent when HIV-positive individuals were unemployed (p=0.037). The mean values for the PHQ-9 (p<0.001), attachment anxiety (p<0.001), attachment avoidance (p<0.001), disclosure concerns (p=0.046), negative self-image (p<0.001), and concerns with public attitudes (p<0.001) were statistically significantly higher for anxious participants than for those without anxiety (Table 4).

Correlation analysis for continuous variables

Participants’ age was positively correlated with ART period (r=0.366) but negatively correlated with attachment anxiety (r=-0.216). Depression (r=0.240) and anxiety symptoms (r=0.173) were positively correlated with ART period. Depression was positively correlated with all measured psychosocial factors: anxiety (r=0.850), attachment avoidance (r=0.333), attachment anxiety (r=0.512), disclosure concerns (r=0.169), negative self-image (r=0.281), and concern with public attitudes (r=0.310). Anxiety also was positively correlated with attachment avoidance (r=0.326), attachment anxiety (r=0.552), disclosure concerns (r=0.182), negative self-image (r=0.299), and concern with public attitudes (r=0.317) (Table 5).

Logistic regression predicting depression and anxiety in PLWH

The variables shown in Tables 6 and 7 are the variables included in the equation in the last step through backward elimination. The analysis indicated that unemployment (odd ratio [OR]=3.068, p=0.048), longer ART period (OR=1.016, p=0.002), higher attachment avoidance (OR=1.076, p=0.049), and higher attachment anxiety (OR=1.130, p<0.001) were significant predictors of depression (Table 6). Further, longer ART period (OR= 1.012, p=0.005), higher attachment anxiety (OR=1.132, p< 0.001), and greater concern with public attitudes (OR=1.203, p=0.022) were significant predictors of anxiety (Table 7).


Sociodemographic and clinical factors associated with depression and anxiety

The gender and age distributions shown in the results were similar to the Korea HIV/AIDS cohort study which investigated the enrollment of PLWH between 2006 and 2016 [38]. And also, for depression and anxiety prevalence, results were similar to past one-month mood disorder diagnosis prevalence shown in a previous US study [39]. In the South Korean cohort study, each severe depressive and anxiety symptom was reported 17.6% and 13.2% at the baseline [38].
The chi-square test and logistic regression analysis results indicate unemployment state and ART period are significantly correlated with depression or anxiety among participants. Unemployment and job loss have been reported to be associated with impaired mental health for a long time. A meta-analysis with 237 cross-sectional and 87 longitudinal studies revealed significant differences in several indicators including distress, depression, anxiety, psychosomatic symptoms, subjective well-being, and self-esteem depending on the employment status [40]. In this context, our findings have similar results to a number of existing studies.
In most previous studies, a long period from the start of ART was not suggested as a predictor for psychological well-being. However, it has been suggested that in those with long-term HIV infection, the persistent activation of immune cells by the virus likely increases the susceptibility of these patients to inflammatory diseases [41]. This reaction can increase the likelihood of other chronic diseases associated with inflammatory reactions in PLWH, and as age increases, its effects can also affect an individual’s psychological well-being [42]. Nevertheless, more research is needed to relate it to mental health over time on ART.

HIV-related stigma as a predictor for depression and anxiety

In our study, the mean score of three subscales of HSS-R is shown to be higher than a previous study conducted in the US, and above all, concern with public attitudes revealed the largest difference in mean score compared with the previous study [27] (Table 2). The stigma associated with this subscale is related to the overall social perception of the disease. Globally, social stigma and discrimination against PLWH are still known as unresolved problems, but in Korea, such problems are found to be much more serious than in Western countries. In a survey released in 2019 by the Korea Center for Disease and Prevention, 52.4% of the 1,000 responders from the general population, said they could not eat a meal with a HIV-infected person [43]. This shows a significant difference from the results of the report for stigmatizing attitudes toward PLWH conducted in the Center for Disease Control and Prevention in the United States, that 17.5% of adults responded that they were afraid of casual contact with HIV-infected persons [44]. Prejudice against PLWH in Korea can be defined as serious in society when to compared with Western societies, it can be predicted that the stigma that patients perceive will also be high [43]. And it has been suggested that negative perceptions of disease affect not only concerns about social attitudes but also the possibility of anticipatory stigma and internalized stigma. This explains why the overall stigma of patients in our study is higher than in the previous study [45].
Internalized stigma, represented by negative self-image in our study, has been argued to have a close connection to mental health in several previous studies as well as the HSF [11,12,45]. In this study, negative self-image was not shown as a predictor in either depression or anxiety. Instead, concern with public attitudes was shown as a predictor of anxiety, which was not significant in depression, but was close to statistical significance. In the correlation study, each stigma subscale including negative self-image has shown to be associated with depression and anxiety, but concerns with public attitudes established a higher degree of correlation. These results can be attributed to the increasingly problematic social stigma in Korea compared to the West. Given its’ high association with mood symptoms, ongoing efforts are necessary to reduce the associated stigma. In South Korea, education continues at the national level to reduce the stigma of HIV and promote related knowledge. As part of such efforts, surveys conducted in 2019, showed a reduction in personal-level stigma and increased knowledge levels, but the social stigma remained problematic [43]. Efforts should continue across the country, communities, and health care institutions to reduce the overall social stigma.
Given the same degree of prediction of mental illness in stigma and attachment security, the stigma did not act as a predictor of depression. Concern with public attitudes is shown to have less statistical significance for predicting anxiety than attachment anxiety. Stigma itself can act as a factor related to depression and anxiety, but its importance as a predictor is less when placed on the same line as attachment anxiety.

Attachment insecurity as a predictor for depression and anxiety

Since the ECR-M16 measure used in our study was not used in other studies with PLWH, simple comparison of mean score was difficult. In an Australian study of attachment security of parents with young children with ECR-M16, both attachment anxiety and attachment avoidance averaged around 16 points, which is significantly lower than our study [46]. Other study with advanced cancer patients, participants showed similar degree of attachment anxiety to our study, but a much lower degree of attachment avoidance [47]. Comparing the two dimensions within the participants to each other also shows attachment avoidance (30.3±8.2) has a much higher mean score compared to attachment anxiety (24.7±10.8). This result shows contrary to several previous studies of HIV positive participants’ attachment insecurity conducted in the United States, in which participants scored slightly higher mean scores in attachment anxiety than attachment avoidance [48-50]. Although there is now a general consensus that the attachment behavioral system is applicable to all humans, there is still a growing body of research devoted to cross-cultural aspects of the attachment system [51]. In other words, cultural differences in each country can affect the attachment security in adulthood and it can change the quality of attachment during lifetime. As mentioned above, prejudice against PLWH in Korea can be serious in society when compared to Western countries, and it can also be considered that such cultural differences may have affected patients’ attachment behavior. This sociocultural influence may have strengthened the aspect of avoiding and suppressing problems rather than facing them and solving them through relationships with others.
Results from both correlation analysis and logistic regression showed a significant correlation between affective symptoms with attachment insecurity. The Pearson correlation test (Table 5) demonstrated that both attachment anxiety and attachment avoidance had a high degree of correlation with depressive and anxiety symptoms. As a result of logistic regression analysis (Tables 6 and 7), attachment anxiety is a predictor of both depression and anxiety. However, attachment avoidance was suggested to be a predictor of depression, but not anxiety. In addition, the result suggests that anxious attachments are more strongly predictive of depression than attachment avoidance, given their odds ratio and statistical significance.
In a meta-analysis published in 2020, authors examined the strength of correlations between two attachment dimensions with depressive symptoms. As a result, attachment anxiety was indicated to be more strongly related to depressive symptoms than attachment avoidance [52]. The authors explained that both attachment dimensions are related to maladaptive emotional regulations, but the different use of strategies had led to this result. Individuals with high attachment anxiety tend to adopt hyperactivating strategies such as focusing on their distress to gain support from others. They usually use emotion focused coping, and this strategy does not relieve painful emotions. However, individuals with high attachment avoidance, usually emphasize self-reliance and often use deactivating strategies like suppressing their negative emotions in stressful situations [53]. This strategy may not bring about a fundamental release of emotions, but in the short term, it may have the effect of preventing distress. In this way, the difference in the effects of two attachment dimensions on depression might be explained, and our research can also be said to have this context.
While many previous studies have shown a high link between attachment anxiety and anxiety disorders, the association with attachment avoidance and anxiety disorders has been somewhat controversial. Several studies have shown that both insecure attachment dimensions are positively associated with anxiety symptoms. However, other studies suggested that the anxious attachment, but not avoidant attachment are related with anxiety symptoms or disorders [54,55]. Individuals with anxiety disorder report that their worry-related cognitions are mostly focused on interpersonal domains. Furthermore, research suggests that anxiety disorder is associated with a tendency to excessively seek support and reassurance from others as a means of reducing anxiety-related pain. This tendency of anxiety disorder patients could be seen as similar in strategy to those with high attachment anxiety, which is somewhat different from those with high attachment avoidance. It is suggested that a more diversified additional approach is needed for the association between avoidance attachment and anxiety disorder, considering the various variables involved.
As mentioned in the discussion related to stigma, our findings differ from previous studies in that attachment insecurity, especially attachment anxiety has precedence over stigma as a predictor of depression and anxiety. As attachment insecurity has emerged as an important psychosocial factor in predicting mental illness in our study, a related therapeutic approach will be important. Previous studies have shown that psychotherapy is an effective way to alleviate depressive symptoms in PLWH [56-58]. We propose that attachment-based psychotherapy will be an excellent intervention to improve mental health among PLWH, as our findings have shown that attachment security has a significant impact on patient’s affective symptoms. Attachment-based psychotherapy is a therapy that attempts to create a secure enough base to explore insecurities around attachment and relationships [59]. Through this intervention, we can expect improvement in patients’ mood symptoms and improvement in overall physical and social psychological health.
In addition, services will be needed to make psychiatric intervention more accessible to patients. PLWH may be reluctant to visit psychiatric clinics due to their own high stigma and above-normal avoidance and anxiety attachment. Therefore, the introduction of integrated health service in which psychiatrists are included in care unit and begin interventions early in diagnosis, could be a way to effectively provide mental health service [58].


Our study has several limitations that should be taken into consideration. First, there may have been a selections bias in including participants in the study. Participants in the study were handed over to the study coordinator after brief explanations and recommendations from the consulting nurse or physician in the survey, and patients who had not been cooperated before meeting the study coordinator were excluded from the study. This leaves open the possibility that those who did not cooperate with the survey may have been more reluctant to ask for help or that their physical or emotional conditions were poor. Second, the study was based on results from a single center, so further studies that include larger sample size and multiple centers are still warranted to validate our findings. Despite these limitations, this study is of great significance in that it is the first study in Korea to determine whether attachment insecurity and stigma are major factors predicting mental illness in PLWH.


Through this study, attachment insecurity was identified as an important factor and is highly correlated to depression and anxiety symptoms in PLWH. Attachment anxiety was presented as a predictor of depression and anxiety, and attachment avoidance was presented as a predictor of depression but not anxiety. The stigma was shown to be both related to depression anxiety symptoms. Concern with public attitudes was presented as a predictor of anxiety, but negative self-image and disclosure concerns did not appear to be a predictor of either depression or anxiety. In conclusion, continuing efforts to reduce stigma at a social level are needed. In addition, attachment-based psychotherapy may be a useful psychiatric intervention to promote PLWH’s mental health, and longitudinal studies evaluating these psychotherapy effects should be conducted in the future.


Availability of Data and Material

The datasets generated or analyzed during the study are available from the corresponding author on reasonable request.

Conflicts of Interest

The authors have no potential conflicts of interest to disclose.

Author Contributions

Conceptualization: all authors. Data curation: Kyungmin Kim, Seoyoung Jang, Shin-Woo Kim, Hyun-ha Chang. Methodology: Kyungmin Kim, Hyo-Deog Rim, Jungmin Woo. Formal analysis: Kyungmin Kim, Jungmin Woo. Investigation: Kyungmin Kim, Seoyoung Jang, Hyo-Deog Rim, Jungmin Woo. Writing—original draft: Kyungmin Kim. Writing—review & editing: Kyungmin Kim, Jungmin Woo.

Funding Statement


Table 1.
Sociodemographic and clinical data of the study participants
Characteristics Value (N=147)*
Age 42.7±12.5
 20-29 yr 26 (17.7)
 30-39 yr 34 (23.1)
 40-49 yr 40 (27.2)
 50-59 yr 31 (21.1)
 60-69 yr 14 (9.5)
 70-79 yr 2 (1.4)
 Male 142 (96.6)
 Female 5 (3.4)
Marital status
 Single 100 (68.0)
 Married 29 (19.7)
 Seperated/divorced/widowed 17 (11.6)
 Yes 96 (65.3)
 No 49 (33.3)
 ≤High school 74 (50.3)
 >High school 72 (49.0)
Monthly income
 ≤3 million KRW 98 (66.7)
 >3 million KRW 42 (28.6)
 Yes 50 (34.0)
 No 96 (65.3)
HIV transmission route
 Homosexual/bisexual 67 (45.6)
 Heterosexual 22 (15.0)
 Injection/blood 1 (7.0)
 Don’t know 55 (37.4)
Experience with AIDS-related diseases
 Yes 46 (31.3)
 No 101 (68.7)
ART adherence
 Very good 132 (89.8)
 Not very good 15 (10.2)
ART period from start (mo) 71.3±58.6
CD4 T-cell count (cells/µL) 610.3±428.7
HIV quant. RT PCR (copies/mL) 8,544.9±87,642.9

Values are presented as mean±standard deviation or number (%).

* sample size might be different in each comparison group due to the missing values in categorical variables.

ART, antiretroviral therapy; HIV quant. RT PCR, HIV quantitative real time polymerase chain reaction

Table 2.
Psychiatric measures of the study participants
Scale Value (N=147)
PHQ-9 5.9±6.3
 <10 115 (78.2)
 ≥10 32 (21.8)
GAD-7 4.4±4.8
 <8 113 (76.9)
 ≥8 34 (23.1)
 Attachment anxiety 24.7±10.8
 Attachment avoidance 30.3±8.2
 Disclosure concerns 25.2±5.1
 Negative self-image 17.8±4.9
 Concerns with public attitudes 19.0±4.2

Values are presented as mean±standard deviation or number (%).

PHQ-9, Patient Health Questionnaire-9; GAD-7, Generalized Anxiety Disorder-7; ECR-M16, Modified Experiences in Close Relationships Scale; HSS-R, HIV Stigma Scale

Table 3.
Results of analyses comparing two groups with or without depression
Without depression (N=115) Depression (N=32) Statistics (χ2 or t) p
Marriage χ2=3.424 0.18
Single 74 (64.9) 26 (81.2)
Married 26 (22.8) 3 (9.4)
Divorced/seperated/widowed 14 (12.3) 3 (9.4)
Total 114 (100) 32 (100)
Employment χ2=6.859 0.009**
Employed 81 (71.7) 15 (46.9)
Umemployed 32 (28.3) 17 (53.1)
Total 113 (100) 32 (100)
Education χ2=3.66 0.056
Low 53 (46.5) 21 (65.6)
High 61 (53.5) 11 (34.4)
Total 114 (100) 32 (100)
Monthly income χ2=0.333 0.564
Low 75 (68.8) 23 (74.2)
High 34 (31.2) 8 (25.8)
Total 109 (100) 31 (100)
Religion χ2=0.163 0.686
Yes 40 (35.1) 10 (31.2)
No 74 (64.9) 22 (68.8)
Total 114 (100) 32 (100)
Experience with AIDS related diseases χ2=0.733 0.392
Yes 34 (29.6) 12 (37.5)
No 81 (70.4) 20 (62.5)
Total 115 (100) 32 (100)
Gender - 0.069
Male 113 (98.3) 29 (90.6)
Female 2 (1.7) 3 (9.4)
Total 115 (100) 32 (100)
HIV transmission route - 0.508
homosexual/bisexual 49 (43.4) 18 (56.3)
Heterosexual 17 (15.0) 5 (15.6)
injection/blood 1 (0.9) 0 (0)
Unknown 46 (40.7) 9 (28.1)
Total 113 (100) 32 (100)
ART adherence - 0.741
Very good 104 (90.4) 28 (87.5)
Not very good 11 (9.6) 4 (12.5)
Total 115 (100) 32 (100)
Age (yr) 42.417±12.879 43.781±11.175 t=-0.544 0.587
ART period from start (mo) 63.870±51.625 98.156±73.465 t=-2.475 0.018*
CD4 T-cell count (cells/µL) 634.086±455.443 524.606±304.953 t=1.281 0.202
HIV quant. RT PCR (copies/mL) 9,197.974±97,908.055 6,197.938±30,287.924 t=0.171 0.865
GAD-7 2.400±2.615 11.594±4.087 t=-12.058 <0.001***
Attachment anxiety 22.261±9.662 33.406±10.426 t=-5.673 <0.001***
Attachment avoidance 28.948±8.202 35.063±6.390 t=-3.897 <0.001***
Disclosure concerns 24.750±5.313 26.683±3.988 t=-1.912 0.058
Negative self-image 17.310±4.838 19.719±4.481 t=-2.530 0.012*
Concerns with public attitudes 18.353±4.364 21.125±2.652 t=-4.465 <0.001***

Values are presented as mean±standard deviation or number (%). Without depression: PHQ-9 <10, Depression: PHQ-9 ≥10.

* p<0.05;

** p<0.01;

*** p<0.001;

sample size might be different in each comparison group due to the missing values in categorical variables;

p-value for Fisher’s exact test.

ART, antiretroviral therapy; HIV quant. RT PCR, HIV quantitative real time polymerase chain reaction; GAD-7, Generalized Anxiety Disorder-7; PHQ-9, Patient Health Questionnaire-9

Table 4.
Results of analyses comparing two groups with or without anxiety
Without anxiety (N=113) Anxiety (N=34) Statistics (χ2 or t) p
Marriage χ2=5.809 0.055
Single 71 (63.4) 29 (85.3)
Married 26 (23.2) 3 (8.8)
Divorced/seperated/widowed 15 (13.4) 2 (5.9)
Total 112 (100) 34 (100)
Employment χ2=5.214 0.037*
Employed 79 (71.2) 17 (50.0)
Umemployed 32 (28.8) 17 (50.0)
Total 111 (100) 34 (100)
Education χ2=1.175 0.330
Low 54 (48.2) 20 (58.8)
High 58 (51.8) 14 (41.2)
Total 112 (100) 34 (100)
Monthly income χ2=2.872 0.128
Low 71 (66.4) 27 (81.8)
High 36 (33.6) 6 (18.2)
Total 107 (100) 33 (100)
Religion χ2=0.071 0.839
Yes 39 (34.8) 11 (32.4)
No 73 (65.2) 23 (67.6)
Total 112 (100) 34 (100)
Experience with AIDS related diseases χ2=2.010 0.205
Yes 32 (28.3) 14 (41.2)
No 81 (71.7) 20 (58.8)
Total 113 (100) 34 (100)
Gender - 0.081
Male 111 (98.2) 31 (91.2)
Female 2 (1.8) 3 (8.8)
Total 113 (100) 34 (100)
HIV transmission route - 0.619
Homosexual/bisexual 48 (43.2) 19 (55.9)
Heterosexual 18 (16.2) 4 (11.8)
Injection/blood 1 (0.9) 0 (0.0)
Unknown 44 (39.7) 11 (32.3)
Total 111 (100) 34 (100)
ART adherence - 0.339
Very good 103 (91.2) 29 (85.3)
Not very good 10 (8.8) 5 (14.7)
Total 113 (100) 34 (100)
Age (yr) 42.947±13.190 41.941±10.021 t=0.474 0.637
ART period from start (mo) 66.248±53.355 88.235±71.582 t=-1.658 0.104
CD4 T-cell count (cells/µL) 637.398±458.874 520.038±295.754 t=1.404 0.162
HIV quant. RT PCR (copies/mL) 9,360.451±98,770.613 5,834.412±29,392.846 t=0.205 0.838
PHQ-9 3.363±3.586 14.265±5.956 t=-10.135 <0.001***
Attachment anxiety 22.018±9.745 33.559±9.542 t=-6.083 <0.001***
Attachment avoidance 29.000±8.330 34.529±6.278 t=-3.574 <0.001***
Disclosure concerns 24.711±5.303 26.699±4.089 t=-2.012 0.046*
Negative self-image 17.094±4.855 20.294±4.004 t=-3.499 <0.001***
Concerns with public attitudes 18.288±4.341 21.176±2.771 t=-4.609 <0.001***

Values are presented as mean±standard deviation or number (%). Without anxiety: GAD-7 <8, Anxiety: GAD-7 ≥8.

* p<0.05;

** p<0.01;

*** p<0.001;

sample size might be different in each comparison group due to the missing values in categorical variables;

p-value for Fisher’s exact test.

ART, antiretroviral therapy; HIV quant. RT PCR, HIV quantitative real time polymerase chain reaction; PHQ-9, Patient Health Questionnaire-9; GAD-7, Generalized Anxiety Disorder-7

Table 5.
Results of Pearson correlation test for continuous variable
1 2 3 4 5 6 7 8 9 10 11
1. Age 1
2. ART period from start 0.366*** 1
3. CD4 T-cell count -0.051 0.057 1
4. HIV quant. RT PCR -0.014 0.068 -0.031 1
5. Depression -0.011 0.240** -0.071 0.018 1
6. Anxiety -0.053 0.173* -0.104 0.066 0.850*** 1
7. Attachment avoidance 0.080 0.069 -0.046 -0.066 0.333*** 0.326*** 1
8. Attachment anxiety -0.216** 0.009 0.022 0.105 0.512*** 0.552*** 0.300*** 1
9. Disclosure concerns 0.031 -0.116 -0.046 -0.057 0.169* 0.182* 0.328*** 0.272** 1
10. Negative self-image 0.023 -0.046 -0.003 -0.085 0.281** 0.299*** 0.244** 0.330*** 0.479*** 1
11. Concerns with public attitude 0.016 -0.028 -0.028 -0.142 0.310*** 0.317*** 0.257** 0.284*** 0.646*** 0.541*** 1

* p<0.05;

** p<0.01;

*** p<0.001.

ART, antiretroviral therapy; HIV quant. RT PCR, HIV quantitative real time polymerase chain reaction

Table 6.
Results of logistic regression analysis for factors predicting depression (PHQ-9 ≥10)
B SE OR 95% CI p
Depression (PHQ-9 ≥10)
Employment 1.121 0.567 3.068 (1.011-9.316) 0.048*
ART period from start 0.016 0.005 1.016 (1.006-1.025) 0.002**
CD4 T-cell count -0.002 0.001 0.998 (0.996-1.000) 0.058
Attachment avoidance 0.073 0.037 1.076 (1.000-1.157) 0.049*
Attachment Anxiety 0.122 0.031 1.130 (1.064-1.200) <0.001***
Concerns with public attitudes 0.167 0.087 1.182 (0.996-1.403) 0.056

-2 Log likelihood=89.766. Nagelkerke R2=0.522. Hosmer & Lemeshow test: χ2=14.650 (p=0.066).

* p<0.05;

** p<0.01;

*** p<0.001.

SE, standard error; OR, odd ratio; CI, confidence interval; GAD-7, Generalized Anxiety Disorder-7; ART, antiretroviral therapy

Table 7.
Results of logistic regression analysis for factors predicting anxiety (GAD-7 ≥8)
B SE OR 95% CI p
Anxiety (GAD-7 ≥8)
 ART period from start 0.012 0.004 1.012 (1.003-1.020) 0.005**
 CD4 T-cell count -0.002 0.001 0.998 (0.996-1.000) 0.057
 Attachment anxiety 0.124 0.028 1.132 (1.071-1.196) <0.001***
 Concern with public attitudes 0.185 0.081 1.203 (1.027-1.409) 0.022*

-2 Log likelihood=104.016. Nagelkerke R2=0.444. Hosmer & Lemeshow test: χ2=3.540 (p=0.896).

* p<0.05;

** p<0.01;

*** p<0.001.

SE, standard error; OR, odd ratio; CI, confidence interval; PHQ-9, Patient Health Questionnaire-9; ART, antiretroviral therapy


1. Nakagawa F, Lodwick RK, Smith CJ, Smith R, Cambiano V, Lundgren JD, et al. Projected life expectancy of people with HIV according to timing of diagnosis. AIDS 2012;26:335-343.
crossref pmid
2. Antiretroviral Therapy Cohort Collaboration. Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies. Lancet HIV 2017;4:e349-e356.
crossref pmid pmc
3. Nakagawa F, May M, Phillips A. Life expectancy living with HIV: recent estimates and future implications. Curr Opin Infect Dis 2013;26:17-25.
4. Samji H, Cescon A, Hogg RS, Modur SP, Althoff KN, Buchacz K, et al. Closing the gap: increases in life expectancy among treated HIV-positive individuals in the United States and Canada. PLoS One 2013;8:e81355
crossref pmid pmc
5. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 2006;3:e442
crossref pmid pmc
6. Nanni MG, Caruso R, Mitchell AJ, Meggiolaro E, Grassi L. Depression in HIV infected patients: a review. Curr Psychiatry Rep 2015;17:530
crossref pmid pdf
7. Ezeamama AE, Woolfork MN, Guwatudde D, Bagenda D, Manabe YC, Fawzi WW, et al. Depressive and anxiety symptoms predict sustained quality of life deficits in HIV-positive Ugandan adults despite antiretroviral therapy: a prospective cohort study. Medicine (Baltimore) 2016;95:e2525
pmid pmc
8. Hill LM, Maman S, Kilonzo MN, Kajula LJ. Anxiety and depression strongly associated with sexual risk behaviors among networks of young men in Dar es Salaam, Tanzania. AIDS Care 2017;29:252-258.
crossref pmid
9. Beer L, Tie Y, Padilla M, Shouse RL, Medical Monitoring Project. Generalized anxiety disorder symptoms among persons with diagnosed HIV in the United States. AIDS 2019;33:1781-1787.
crossref pmid
10. Qiu Y, Luo D, Cheng R, Xiao Y, Chen X, Huang Z, et al. [Emotional problems and related factors in patients with HIV/AIDS]. Zhong Nan Da Xue Xue Bao Yi Xue Ban 2014;39:835-841. Chinese.
11. Earnshaw VA, Chaudoir SR. From conceptualizing to measuring HIV stigma: a review of HIV stigma mechanism measures. AIDS Behav 2009;13:1160-1177.
crossref pmid pmc pdf
12. Earnshaw VA, Smith LR, Chaudoir SR, Amico KR, Copenhaver MM. HIV stigma mechanisms and well-being among PLWH: a test of the HIV stigma framework. AIDS Behav 2013;17:1785-1795.
crossref pmid pmc pdf
13. Stangl AL, Lloyd JK, Brady LM, Holland CE, Baral S. A systematic review of interventions to reduce HIV-related stigma and discrimination from 2002 to 2013: how far have we come? J Int AIDS Soc 2013;16(3 Suppl 2):18734
crossref pmid pmc pdf
14. Bennett JK, Fuertes JN, Keitel M, Phillips R. The role of patient attachment and working alliance on patient adherence, satisfaction, and health-related quality of life in lupus treatment. Patient Educ Couns 2011;85:53-59.
crossref pmid
15. Ciechanowski P, Russo J, Katon W, Von Korff M, Ludman E, Lin E, et al. Influence of patient attachment style on self-care and outcomes in diabetes. Psychosom Med 2004;66:720-728.
crossref pmid
16. Nicholls W, Hulbert-Williams N, Bramwell R. The role of relationship attachment in psychological adjustment to cancer in patients and caregivers: a systematic review of the literature. Psychooncology 2014;23:1083-1095.
crossref pmid
17. Bowlby J. Attachment and loss. Volume II. Separation, anxiety and anger. London: The Hogarth Press and The Institute of Psychoanalysis, 1973, p.1-429.

18. Mikulincer M, Shaver PR. Attachment in adulthood: structure, dynamics, and change. New York: Guilford Press; 2007.

19. Sable P. What is adult attachment? Clin Soc Work J 2008;36:21-30.
crossref pdf
20. Chopik WJ, Edelstein RS, Grimm KJ. Longitudinal changes in attachment orientation over a 59-year period. J Pers Soc Psychol 2019;116:598-611.
crossref pmid
21. Tedstone JE, Tarrier N. Posttraumatic stress disorder following medical illness and treatment. Clin Psychol Rev 2003;23:409-448.
crossref pmid
22. O’Connor M, Elklit A. Attachment styles, traumatic events, and PTSD: a cross-sectional investigation of adult attachment and trauma. Attach Hum Dev 2008;10:59-71.
crossref pmid
23. Davis KB. Understanding and addressing stigma and attachment insecurity in HIV-positive women who experience intimate partner violence: a model of medical and psychosocial care. Soc Work Health Care 2012;51:213-231.
crossref pmid
24. Koopman C, Gore-Felton C, Marouf F, Butler LD, Field N, Gill M, et al. Relationships of perceived stress to coping, attachment and social support among HIV-positive persons. AIDS Care 2000;12:663-672.
crossref pmid
25. Turner-Cobb JM, Gore-Felton C, Marouf F, Koopman C, Kim P, Israelski D, et al. Coping, social support, and attachment style as psychosocial correlates of adjustment in men and women with HIV/AIDS. J Behav Med 2002;25:337-353.
26. Turan B, Crockett KB, Buyukcan-Tetik A, Kempf MC, Konkle-Parker D, Wilson TE, et al. Buffering internalization of HIV-stigma: implications for treatment adherence and depression. J Acquir Immune Defic Syndr 2019;80:284-291.
crossref pmid pmc
27. Bunn JY, Solomon SE, Miller C, Forehand R. Measurement of stigma in people with HIV: a reexamination of the HIV stigma scale. AIDS Educ Prev 2007;19:198-208.
crossref pmid
28. Berger BE, Ferrans CE, Lashley FR. Measuring stigma in people with HIV: psychometric assessment of the HIV stigma scale. Res Nurs Health 2001;24:518-529.
crossref pmid
29. Lo C, Walsh A, Mikulincer M, Gagliese L, Zimmermann C, Rodin G. Measuring attachment security in patients with advanced cancer: psychometric properties of a modified and brief Experiences in Close Relationships scale. Psychooncology 2009;18:490-499.
crossref pmid
30. Brennan KA, Clark CL, Shaver PR. Self-report measurement of adult attachment: an integrative overview. In: Simpson JA, Rholes WS, editor. Attachment theory and close relationships. New York: Guilford Press, 1998, p. 46-76.

31. Lee SS, Rim HD, Won SH, Woo J. Avoidant insecure attachment as a predictive factor for psychological distress in patients with early breast cancer: a preliminary 1-year follow-up study. Psychiatry Investig 2018;15:805-810.
crossref pmid pmc pdf
32. Jang B, Rim HD, Woo J. Reliability and validity of the Korean version of the modified adult attachment scale for the use of medically ill patients. Psychiatry Investig 2015;12:483-490.
crossref pmid pmc
33. Han C, Jo SA, Kwak JH, Pae CU, Steffens D, Jo I, et al. Validation of the Patient Health Questionnaire-9 Korean version in the elderly population: the Ansan geriatric study. Compr Psychiatry 2008;49:218-223.
crossref pmid
34. Moriarty AS, Gilbody S, McMillan D, Manea L. Screening and case finding for major depressive disorder using the Patient Health Questionnaire (PHQ-9): a meta-analysis. Gen Hosp Psychiatry 2015;37:567-576.
crossref pmid
35. Lee S, Huh Y, Kim J. Finding optimal cut off points of the Korean version of the Patient Health Questionnaire-9 (PHQ-9) for screening depressive disorders. Mood Emot 2014;12:32-36.

36. Spitzer RL, Kroenke K, Williams JB, Löwe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med 2006;166:1092-1097.
crossref pmid
37. Ahn JK, Kim Y, Choi KH. The psychometric properties and clinical utility of the Korean version of GAD-7 and GAD-2. Front Psychiatry 2019;10:127
crossref pmid pmc
38. Choi BY, Choi JY, Han SH, Kim SI, Kee MK, Kim MJ, et al. Korea HIV/AIDS cohort study: study design and baseline characteristics. Epidemiol Health 2018;40:e2018023
crossref pmid pmc
39. Gaynes BN, Pence BW, Eron JJ Jr, Miller WC. Prevalence and comorbidity of psychiatric diagnoses based on reference standard in an HIV+ patient population. Psychosom Med 2008;70:505-511.
crossref pmid pmc
40. Paul KI, Moser K. Unemployment impairs mental health: meta-analyses. J Vocat Behav 2009;74:264-282.
41. Appay V, Sauce D. Immune activation and inflammation in HIV-1 infection: causes and consequences. J Pathol 2008;214:231-241.
crossref pmid
42. Balderson BH, Grothaus L, Harrison RG, McCoy K, Mahoney C, Catz S. Chronic illness burden and quality of life in an aging HIV population. AIDS Care 2013;25:451-458.
crossref pmid
43. Cha J, Hwang SH, Oh EJ, Yun J, Kong I. State public relations policy for AIDS prevention in South Korea. Public Health Wkly Rep 2019;12:2151-2159.

44. Pitasi MA, Chavez PR, DiNenno EA, Jeffries WL 4th, Johnson CH, Demeke H, et al. Stigmatizing attitudes toward people living with HIV among adults and adolescents in the United States. AIDS Behav 2018;22:3887-3891.
crossref pmid pmc pdf
45. Turan B, Budhwani H, Fazeli PL, Browning WR, Raper JL, Mugavero MJ, et al. How does stigma affect people living with HIV? The mediating roles of internalized and anticipated HIV stigma in the effects of perceived community stigma on health and psychosocial outcomes. AIDS Behav 2017;21:283-291.
crossref pmid pmc pdf
46. Branjerdporn G, Meredith P, Strong J, Green M. Sensory sensitivity and its relationship with adult attachment and parenting styles. PLoS One 2019;14:e0209555
crossref pmid pmc
47. Scheffold K, Philipp R, Koranyi S, Engelmann D, Schulz-Kindermann F, Härter M, et al. Insecure attachment predicts depression and death anxiety in advanced cancer patients. Palliat Support Care 2018;16:308-316.
crossref pmid
48. Martin LA, Vosvick M, Riggs SA. Attachment, forgiveness, and physical health quality of life in HIV + adults. AIDS Care 2012;24:1333-1340.
crossref pmid
49. Blake Helms C, Turan JM, Atkins G, Kempf MC, Clay OJ, Raper JL, et al. Interpersonal mechanisms contributing to the association between HIV-related internalized stigma and medication adherence. AIDS Behav 2017;21:238-247.
crossref pmid pmc pdf
50. Turan B, Crockett KB, Kempf MC, Konkle-Parker D, Wilson TE, Tien PC, et al. Internal working models of attachment relationships and HIV outcomes among women living with HIV. J Acquir Immune Defic Syndr 2019;80:e1-e8.
crossref pmid pmc
51. Agishtein P, Brumbaugh C. Cultural variation in adult attachment: the impact of ethnicity, collectivism, and country of origin. J Soc Evol Cult Psychol 2013;7:384
52. Zheng L, Luo Y, Chen X. Different effects of attachment anxiety and attachment avoidance on depressive symptoms: a meta-analysis. J Soc Pers Relatsh 2020;37:3028-3050.
crossref pdf
53. Mikulincer M, Shaver PR. The attachment behavioral system in adulthood: activation, psychodynamics, and interpersonal processes. Adv Exp Soc Psychol 2003;35:53-152.
54. Nielsen SKK, Lønfeldt N, Wolitzky-Taylor KB, Hageman I, Vangkilde S, Daniel SIF. Adult attachment style and anxiety - The mediating role of emotion regulation. J Affect Disord 2017;218:253-259.
crossref pmid
55. Marganska A, Gallagher M, Miranda R. Adult attachment, emotion dysregulation, and symptoms of depression and generalized anxiety disorder. Am J Orthopsychiatry 2013;83:131-141.
crossref pmid
56. Lofgren SM, Nakasujja N, Boulware DR. Systematic review of interventions for depression for people living with HIV in Africa. AIDS Behav 2018;22:1-8.
crossref pdf
57. Nakimuli-Mpungu E, Wamala K, Okello J, Ndyanabangi S, Kanters S, Mojtabai R, et al. Process evaluation of a randomized controlled trial of group support psychotherapy for depression treatment among people with HIV/AIDS in Northern Uganda. Community Ment Health J 2017;53:991-1004.
crossref pmid pmc pdf
58. Jang S, Rim HD, Kim K, Kim BS, Woo J. Psychiatric understanding and treatment consideration in HIV infection. J Korean Soc Biol Ther Psychiatry 2020;26:184-194.

59. Schwartz J, Pollard J. Introduction to the special issue: attachment-based psychoanalytic psychotherapy. Attach Hum Dev 2004;6:113-115.


Browse all articles >

Editorial Office
#522, 27, Seochojungang-ro 24-gil, Seocho-gu, Seoul 06601, Korea
Tel: +82-2-717-0892    E-mail:                

Copyright © 2023 by Korean Neuropsychiatric Association.

Developed in M2PI

Close layer
prev next